Evidence map›Paper›PMID 28892020›Full record

ArticleAntibiotics (Basel, Switzerland)2017

Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray.

William R Schwan, Rebecca Polanowski, Paul M Dunman, Sara Medina-Bielski, Michelle Lane, Marc Rott, Lauren Lipker, Amy Wescott, Aaron Monte, James M Cook and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Global Transcriptional Differences inAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

William R SchwanDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. wschwan@uwlax.edu.
Rebecca PolanowskiDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. rpolanowski@uwlax.edu.
Paul M DunmanSchool of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA. paul_dunman@urmc.rochester.edu.
Sara Medina-BielskiDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. s.medinabielski@gmail.com.
Michelle LaneDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. lanem7285@gmail.com.
Marc RottDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. mrott@uwlax.edu.
Lauren LipkerDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. lipker.laur@uwlax.edu.
Amy WescottDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. amywescott16@gmail.com.
Aaron MonteEmerging Technology Center for Pharmaceutical Development, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. amonte@uwlax.edu.
James M CookDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. capncook@uwm.edu.
Douglas D BaumannDepartment of Mathematics and Statistics, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. dbaumann@uwlax.edu.
V V N Phani Babu TiruveedhulaDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. tiruvee2@uwm.edu.
Christopher M WitzigmannDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. witzigm2@uwm.edu.
Cassandra MikelDepartment of Microbiology, University of Wisconsin-La Crosse, La Crosse, WI 54601, USA. cassandra.mm010@gmail.com.
Md Toufiqur RahmanDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. mdrahman@uwm.edu.
University of Wisconsin–La Crosse · USUniversity of Wisconsin–Milwaukee · USUniversity of Rochester · US

Funding

Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic PainR01NS076517 · NINDS · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COOK, JAMES M · 2012 to 2015
$1.3M
NINDS NIH HHS R01 NS076517
6 · The paper itself

Abstract

The mechanism of action for a new lead stilbene compound coded SK-03-92 with bactericidal activity against methicillin-resistant

Indexed as

biofilmdrug mechanism of actiongene regulationmicroarraysortaseStaphylococcus aureusstilbene

Identifiers

PMID28892020
PMCPMC5617981
OpenAlexW2754507796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.